Company: TAK
Filing Date: 2025-10-30
Form Type: 6-K
Source: 0001395064-25-000154
Chunk: 38

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-10-30
Form: 6-K
Chunk 38
---
 Company) is as follows:

|                                                                                                          |     | Six-month Period Ended September 30, |      2024 |     |     |      2025 |
|:---------------------------------------------------------------------------------------------------------|:----|:-------------------------------------|----------:|:----|:----|----------:|
| Net profit for the period attributable to owners of the Company                                          |     |                                      |           |     |     |           |
| Net profit for the period attributable to owners of the Company (million JPY)                            |     |                                      |   187,294 |     |     |   112,441 |
| Net profit used for calculation of earnings per share (million JPY)                                      |     |                                      |   187,294 |     |     |   112,441 |
| Weighted average number of ordinary shares outstanding during the period (thousands of shares) [basic]   |     |                                      | 1,575,882 |     |     | 1,571,098 |
| Dilutive effect (thousands of shares)                                                                    |     |                                      |    23,415 |     |     |    24,834 |
| Weighted average number of ordinary shares outstanding during the period (thousands of shares) [diluted] |     |                                      | 1,599,296 |     |     | 1,595,932 |
| Earnings per share                                                                                       |     |                                      |           |     |     |           |
| Basic earnings per share (JPY)                                                                           |     |                                      |    118.85 |     |     |     71.57 |
| Diluted earnings per share (JPY)                                                                         |     |                                      |    117.11 |     |     |     70.45 |

<div align='center'>- 34 -</div>

Translation for reference purpose only

#### ９. Bonds and Loans
During the six-month period ended September 30, 2025, Takeda had the following movements in the bonds and loans.

(1) Bonds

#### Issuance
JPY Unsecured Senior Notes:

| Issuance Date                   |     | June 2025                     |
| Issue Amount (Principal Amount) |     | JPY 184,000 million           |
| Coupon Rate                     |     | 1.599 - 2.292% per annum      |
| Issue Price                     |     | 100% of the principal amount  |
| Maturity Date